semaglutide end date Two-year effects of in adults with overweight or obesity: the STEP 5 trial Switching between weight-loss medications -

[9] [10] Importantly, the VAT-reducing effect of tesamorelin diminishes after treatment is stopped, and VAT can reaccumulate following discontinuation

hon ton c th gy suy gan, suy thn

(The exact reason isnt entirely clearthere could be a metabolic rebound happening in the body or, the simplest explanation, your appetite came back.) Knowing that the weight lost while on a GLP-1 might return, its important to anticipate the modifications you might need to make, and consider some realistic ways to adjust your diet, become more physically active, get enough sleep, and most importantly, take care of your mental health

Studies link excess subcutaneous belly fat to insulin resistance and type 2 diabetes, as well as imbalances in estrogen, leptin and other key hormones that influence how your body stores fat and regulates appetite

Regular follow-up appointments allow for careful evaluation of dosing strategies and possible integration of complementary approaches